These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17564972)

  • 1. Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4.
    Stendel C; Roos A; Deconinck T; Pereira J; Castagner F; Niemann A; Kirschner J; Korinthenberg R; Ketelsen UP; Battaloglu E; Parman Y; Nicholson G; Ouvrier R; Seeger J; De Jonghe P; Weis J; Krüttgen A; Rudnik-Schöneborn S; Bergmann C; Suter U; Zerres K; Timmerman V; Relvas JB; Senderek J
    Am J Hum Genet; 2007 Jul; 81(1):158-64. PubMed ID: 17564972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells.
    Horn M; Baumann R; Pereira JA; Sidiropoulos PN; Somandin C; Welzl H; Stendel C; Lühmann T; Wessig C; Toyka KV; Relvas JB; Senderek J; Suter U
    Brain; 2012 Dec; 135(Pt 12):3567-83. PubMed ID: 23171661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H.
    Delague V; Jacquier A; Hamadouche T; Poitelon Y; Baudot C; Boccaccio I; Chouery E; Chaouch M; Kassouri N; Jabbour R; Grid D; Mégarbané A; Haase G; Lévy N
    Am J Hum Genet; 2007 Jul; 81(1):1-16. PubMed ID: 17564959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot-Marie-Tooth disease 4H.
    El-Bazzal L; Ghata A; Estève C; Gadacha J; Quintana P; Castro C; Roeckel-Trévisiol N; Lembo F; Lenfant N; Mégarbané A; Borg JP; Lévy N; Bartoli M; Poitelon Y; Roubertoux PL; Delague V; Bernard-Marissal N
    Brain; 2023 May; 146(5):1844-1858. PubMed ID: 36314052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence that mutations in FGD4/frabin cause Charcot-Marie-Tooth disease type 4H.
    Fabrizi GM; Taioli F; Cavallaro T; Ferrari S; Bertolasi L; Casarotto M; Rizzuto N; Deconinck T; Timmerman V; De Jonghe P
    Neurology; 2009 Mar; 72(13):1160-4. PubMed ID: 19332693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Mutation in Frabin (FGD4) Causing a Mild Phenotype of CMT4H in an Indian Patient.
    Nishadham V; Santhoshkumar R; Nashi S; Vengalil S; Bardhan M; Polavarapu K; Sanka SB; Anjanappa RM; Kulanthaivelu K; Saini J; Chickabasaviah YT; Nalini A
    J Neuromuscul Dis; 2024; 11(1):221-232. PubMed ID: 38108359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in FGD4/FRABIN causes Charcot Marie Tooth disease type 4H in patients from a consanguineous Tunisian family.
    Boubaker C; Hsairi-Guidara I; Castro C; Ayadi I; Boyer A; Kerkeni E; Courageot J; Abid I; Bernard R; Bonello-Palot N; Kamoun F; Cheikh HB; Lévy N; Triki C; Delague V
    Ann Hum Genet; 2013 Jul; 77(4):336-43. PubMed ID: 23550889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Frabin (FGD4) nonsense mutation p.R275X associated with phenotypic variability in CMT4H.
    Houlden H; Hammans S; Katifi H; Reilly MM
    Neurology; 2009 Feb; 72(7):617-20. PubMed ID: 19221294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model.
    Florio F; Ferri C; Scapin C; Feltri ML; Wrabetz L; D'Antonio M
    J Neurosci; 2018 May; 38(18):4275-4287. PubMed ID: 29610440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.
    Boyer O; Nevo F; Plaisier E; Funalot B; Gribouval O; Benoit G; Huynh Cong E; Arrondel C; Tête MJ; Montjean R; Richard L; Karras A; Pouteil-Noble C; Balafrej L; Bonnardeaux A; Canaud G; Charasse C; Dantal J; Deschenes G; Deteix P; Dubourg O; Petiot P; Pouthier D; Leguern E; Guiochon-Mantel A; Broutin I; Gubler MC; Saunier S; Ronco P; Vallat JM; Alonso MA; Antignac C; Mollet G
    N Engl J Med; 2011 Dec; 365(25):2377-88. PubMed ID: 22187985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves.
    Okuda T; Higashi Y; Kokame K; Tanaka C; Kondoh H; Miyata T
    Mol Cell Biol; 2004 May; 24(9):3949-56. PubMed ID: 15082788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination.
    Hu B; McCollum M; Ravi V; Arpag S; Moiseev D; Castoro R; Mobley B; Burnette B; Siskind C; Day J; Yawn R; Feely S; Li Y; Yan Q; Shy M; Li J
    Ann Neurol; 2018 Apr; 83(4):756-770. PubMed ID: 29518270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
    Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
    Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.
    Vijay S; Chiu M; Dacks JB; Roberts RC
    Biochim Biophys Acta; 2016 Jul; 1862(7):1279-90. PubMed ID: 27068304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel missense mutations in FGD4/FRABIN cause Charcot-Marie-Tooth type 4H (CMT4H).
    Baudot C; Esteve C; Castro C; Poitelon Y; Mas C; Hamadouche T; El-Rajab M; Lévy N; Megarbané A; Delague V
    J Peripher Nerv Syst; 2012 Jun; 17(2):141-6. PubMed ID: 22734899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic characterization of INF2-related Charcot-Marie-Tooth disease: evidence for a Schwann cell actinopathy.
    Mathis S; Funalot B; Boyer O; Lacroix C; Marcorelles P; Magy L; Richard L; Antignac C; Vallat JM
    J Neuropathol Exp Neurol; 2014 Mar; 73(3):223-33. PubMed ID: 24487800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverted formin 2-related Charcot-Marie-Tooth disease: extension of the mutational spectrum and pathological findings in Schwann cells and axons.
    Roos A; Weis J; Korinthenberg R; Fehrenbach H; Häusler M; Züchner S; Mache C; Hubmann H; Auer-Grumbach M; Senderek J
    J Peripher Nerv Syst; 2015 Mar; 20(1):52-9. PubMed ID: 25676889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease.
    Kessali M; Zemmouri R; Guilbot A; Maisonobe T; Brice A; LeGuern E; Grid D
    Neurology; 1997 Apr; 48(4):867-73. PubMed ID: 9109869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.